OptiBiotix offers UK probiotic supplements
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
UK-based probiotics manufacturer OptiBiotix Health is launching in the UK a new supplement based on its patented lactobacillus plantarum, LPLDL, probiotic strain, aimed at the management of cholesterol.
You may also be interested in...
OptiBiotix Health Strikes Deal To Take CholBiome Probiotic Into Russia And Kazakhstan
British probiotic specialist OptiBiotix Health has struck a three-year distribution deal for its CholBiome supplement in Russia and Kazakhstan.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.